Literature DB >> 7626110

Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes.

M L Kuo1, N C Yang.   

Abstract

Apigenin, a plant flavonoid, induced the reversion of transformed phenotypes of v-H-ras-transformed NIH 3T3 cells at a quite low concentration of 12.5 microM. In the present study, we have examined the components of this Ras-mediated signaling transduction to determine whether they were involved in the apigenin-induced reversion process. Interestingly, the consitutively activated mitogen activated protein kinase (MAPK) in the ras transformant was inhibited significantly and rapidly by 25 microM apigenin within 30 min, and this reduction continued for more than 4 h. Corroborating these observations, expression of the downstream oncogenes c-jun and c-fos was also dramatically reduced during the first 4 h of treatment. We found that the levels of ras protein and mRNA were not affected by 24 h of treatment with apigenin. These findings indicate that apigenin-induced reversion of v-H-ras-transformed NIH 3T3 cells may occur by inhibiting MAPK activity and its downstream oncogenes rather than by affecting the expression of the ras gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626110     DOI: 10.1006/bbrc.1995.2035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Intracellular signals that control cell proliferation in mammalian balance epithelia: key roles for phosphatidylinositol-3 kinase, mammalian target of rapamycin, and S6 kinases in preference to calcium, protein kinase C, and mitogen-activated protein kinase.

Authors:  M Montcouquiol; J T Corwin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

2.  Differential cAMP gating of glutamatergic signaling regulates long-term state changes in the suprachiasmatic circadian clock.

Authors:  S A Tischkau; E A Gallman; G F Buchanan; M U Gillette
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Inhibitory effects of apigenin on the growth of gastric carcinoma SGC-7901 cells.

Authors:  Kun Wu; Lin-Hong Yuan; Wei Xia
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

4.  Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells.

Authors:  Margareta Berggren; Sivanandane Sittadjody; Zuohe Song; Jean-Louis Samira; Randy Burd; Emmanuelle J Meuillet
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

5.  Investigation into the involvement of phospholipases A(2) and MAP kinases in modulation of AA release and cell growth in A549 cells.

Authors:  Q G Choudhury; D T McKay; R J Flower; J D Croxtall
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 6.  Phytochemicals for the Prevention of Photocarcinogenesis.

Authors:  Mary K Montes de Oca; Ross L Pearlman; Sarah F McClees; Rebecca Strickland; Farrukh Afaq
Journal:  Photochem Photobiol       Date:  2017-03-14       Impact factor: 3.421

7.  The influence of hollyhock extract administration on testicular function in rats.

Authors:  Monika A Papiez
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

8.  Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition.

Authors:  Xin Tong; Rukiyah T Van Dross; Adnan Abu-Yousif; Aubrey R Morrison; Jill C Pelling
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

Review 9.  Apoptotic effects of chrysin in human cancer cell lines.

Authors:  Boon Yin Khoo; Siang Ling Chua; Prabha Balaram
Journal:  Int J Mol Sci       Date:  2010-05-19       Impact factor: 5.923

10.  Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner.

Authors:  Caleb M Bailey; Daniel E Abbott; Naira V Margaryan; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.